Phibro Animal Health (PAHC) Tops Q3 EPS by 10c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts PAHC Hot Sheet
Join SI Premium – FREE
Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.63, $0.10 better than the analyst estimate of $0.53. Revenue for the quarter came in at $347.8 million versus the consensus estimate of $309.5 million.
GUIDANCE:
Phibro Animal Health sees FY2025 EPS of $1.96-$2.09, versus the consensus of $1.94. Phibro Animal Health sees FY2025 revenue of $1.26-1.29 billion, versus the consensus of $1.28 billion.
For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Graco Inc. (GGG) PT Lowered to $80 at DA Davidson
- SS&C Technologies shares fall on weak Q4 revenue outlook
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
